Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 189

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 189
---
shares as are conferred by a resolution of the stockholders at an annual or special meeting. The Nevada control share law, if applicable,
could have the effect of discouraging takeovers of our company.

Transfer Agent and Registrar

We have retained Transfer Online, Inc. located
at 512 SE Salmon Street Portland, OR 97214; phone (503) 227-2950 as the transfer agent for our Common Stock.

<div align='center'>116

SHARES ELIGIBLE FOR FUTURE SALE</div>

Market sales of shares of our Common Stock after
this Offering and from time to time, and the availability of shares for future sale, may reduce the market price of our Common Stock.
Sales of substantial amounts of our Common Stock, or the perception that these sales could occur, could adversely affect prevailing market
prices for our Common Stock and could impair our future ability to obtain capital, especially through an offering of equity securities.
After the effective date of the registration statement of which this Prospectus is a part, all of the shares registered in this Offering
will be freely tradable without restrictions or further registration under the Securities Act of 1933, unless the shares are purchased
by our affiliates, as that term is defined in Rule 144 under the Securities Act. The balance of shares which are not being registered
will be eligible for sale pursuant to exemptions from registration. However, these shares not being registered are held by our management
and other affiliates who are limited to selling only 1% of our issued and outstanding shares every 90 days.

Our Common Stock is considered a “penny
stock” and will continue to be considered a penny stock so long as it trades below $5.00 per share and, as such, trading in our
Common Stock is subject to the requirements of Rule 15g-9 under the Securities Exchange Act of 1934. Under this rule, broker/dealers who
recommend low-priced securities to persons other than established customers and accredited investors must satisfy special sales practice
requirements. The broker/dealer must make an individualized written suitability determination for the purchaser and receive the purchaser’s
written consent prior to the transaction.

SEC regulations also require additional disclosure
in connection with any trades involving a “penny stock,” including the delivery, prior to any penny stock transaction, of
a disclosure schedule explaining the penny stock market and its associated risks. In addition, broker-dealers must disclose commissions
payable to both the broker-dealer and the registered representative and current quotations for the securities